Ewing Sarcoma
New drug combo improves survival in rare, aggressive bone cancer
Published in Cancer Weekly, March 11th, 2003
The large multi-institutional trial led by Holcombe E. Grier, MD, of Dana-Farber Cancer Institute and Children's Hospital Boston, showed that the overall survival rate increased from 61% to 72% for Ewing sarcoma patients with localized disease who underwent the experimental six-drug chemotherapy.
Conducted by members of two large North American pediatric cancer research groups and published in the New...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2003-03-11)
More Articles from Cancer Weekly
- Colorectal Cancer
Gene appears to play important important role in controlling growth of cells - Adrenal Masses
Upregulation of 17-OHP can be measured to identify patients with malignancies - Cancer Therapy
Targeting DNA gives powerful cancer drug extra boost in shrinking tumors - Cell Biology
Researcher explores tumors' survival strategy - Liver Cancer
Cryosurgery kills cells - Acute Leukemia
Researchers have completed a phase 1 study of antisense therapy G3139 - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
